Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 285Head and Neck Neoplasms 250Carcinoma, Non-Small-Cell Lung 95Thyroid Neoplasms 92Melanoma 68Mouth Neoplasms 67Nasopharyngeal Carcinoma 64Oropharyngeal Neoplasms 63Breast Neoplasms 54Colorectal Neoplasms 49Lung Neoplasms 47Ovarian Neoplasms 45Neoplasm Metastasis 45Neoplasms 41Uterine Cervical Neoplasms 39Carcinoma, Squamous Cell 39Carcinoma, Renal Cell 34Triple Negative Breast Neoplasms 31Stomach Neoplasms 31Laryngeal Neoplasms 31Endometrial Neoplasms 29Carcinoma 29Sarcoma 28Esophageal Neoplasms 28Pancreatic Neoplasms 27Salivary Gland Neoplasms 26Prostatic Neoplasms 25Thyroid Cancer, Papillary 23Urinary Bladder Neoplasms 22Hypopharyngeal Neoplasms 22

Interventions

Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinocerebellar Degenerations × Head & Neck × 90 days × Clear all
NCT06544655 2026-04-17

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Active not recruiting
213 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡